These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 10971094

  • 1. Response to treatment in patients with partial androgen insensitivity due to mutations in the DNA-binding domain of the androgen receptor.
    Lundberg Giwercman Y, Nikoshkov A, Lindsten K, Byström B, Pousette A, Knudtzon J, Alm J, Wedell A.
    Horm Res; 2000; 53(2):83-8. PubMed ID: 10971094
    [Abstract] [Full Text] [Related]

  • 2. Discordant measures of androgen-binding kinetics in two mutant androgen receptors causing mild or partial androgen insensitivity, respectively.
    Shkolny DL, Beitel LK, Ginsberg J, Pekeles G, Arbour L, Pinsky L, Trifiro MA.
    J Clin Endocrinol Metab; 1999 Feb; 84(2):805-10. PubMed ID: 10022458
    [Abstract] [Full Text] [Related]

  • 3. Complete androgen insensitivity syndrome caused by a novel mutation in the ligand-binding domain of the androgen receptor: functional characterization.
    Rosa S, Biason-Lauber A, Mongan NP, Navratil F, Schoenle EJ.
    J Clin Endocrinol Metab; 2002 Sep; 87(9):4378-82. PubMed ID: 12213902
    [Abstract] [Full Text] [Related]

  • 4. Disrupted amino- and carboxyl-terminal interactions of the androgen receptor are linked to androgen insensitivity.
    Thompson J, Saatcioglu F, Jänne OA, Palvimo JJ.
    Mol Endocrinol; 2001 Jun; 15(6):923-35. PubMed ID: 11376111
    [Abstract] [Full Text] [Related]

  • 5. A G577R mutation in the human AR P box results in selective decreases in DNA binding and in partial androgen insensitivity syndrome.
    Nguyen D, Steinberg SV, Rouault E, Chagnon S, Gottlieb B, Pinsky L, Trifiro M, Mader S.
    Mol Endocrinol; 2001 Oct; 15(10):1790-802. PubMed ID: 11579211
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Functional characterisation of mutations in the ligand-binding domain of the androgen receptor gene in patients with androgen insensitivity syndrome.
    Lundberg Giwercman Y, Nikoshkov A, Lindsten K, Byström B, Pousette A, Chibalin AV, Arvidsson S, Tiulpakov A, Semitcheva TV, Peterkova V, Hagenfeldt K, Ritzén EM, Wedell A.
    Hum Genet; 1998 Oct; 103(4):529-31. PubMed ID: 9856504
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A novel substitution (Leu707Arg) in exon 4 of the androgen receptor gene causes complete androgen resistance.
    Lumbroso S, Lobaccaro JM, Georget V, Leger J, Poujol N, Térouanne B, Evain-Brion D, Czernichow P, Sultan C.
    J Clin Endocrinol Metab; 1996 May; 81(5):1984-8. PubMed ID: 8626869
    [Abstract] [Full Text] [Related]

  • 10. The use of androgen receptor amino/carboxyl-terminal interaction assays to investigate androgen receptor gene mutations in subjects with varying degrees of androgen insensitivity.
    Ghali SA, Gottlieb B, Lumbroso R, Beitel LK, Elhaji Y, Wu J, Pinsky L, Trifiro MA.
    J Clin Endocrinol Metab; 2003 May; 88(5):2185-93. PubMed ID: 12727974
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. L712V mutation in the androgen receptor gene causes complete androgen insensitivity syndrome due to severe loss of androgen function.
    Rajender S, Gupta NJ, Chakrabarty B, Singh L, Thangaraj K.
    Steroids; 2013 Dec 11; 78(12-13):1288-92. PubMed ID: 24055831
    [Abstract] [Full Text] [Related]

  • 13. A naturally occurring mutation in the human androgen receptor of a subject with complete androgen insensitivity confers binding and transactivation by estradiol.
    Bonagura TW, Deng M, Brown TR.
    Mol Cell Endocrinol; 2007 Jan 15; 263(1-2):79-89. PubMed ID: 17011702
    [Abstract] [Full Text] [Related]

  • 14. Androgen receptor exon 1 mutation causes androgen insensitivity by creating phosphorylation site and inhibiting melanoma antigen-A11 activation of NH2- and carboxyl-terminal interaction-dependent transactivation.
    Lagarde WH, Blackwelder AJ, Minges JT, Hnat AT, French FS, Wilson EM.
    J Biol Chem; 2012 Mar 30; 287(14):10905-15. PubMed ID: 22334658
    [Abstract] [Full Text] [Related]

  • 15. Novel mutation in the ligand-binding domain of the androgen receptor gene (l790p) associated with complete androgen insensitivity syndrome.
    Raicu F, Giuliani R, Gatta V, Palka C, Franchi PG, Lelli-Chiesa P, Tumini S, Stuppia L.
    Asian J Androl; 2008 Jul 30; 10(4):687-91. PubMed ID: 18097502
    [Abstract] [Full Text] [Related]

  • 16. Impaired nuclear translocation, nuclear matrix targeting, and intranuclear mobility of mutant androgen receptors carrying amino acid substitutions in the deoxyribonucleic acid-binding domain derived from androgen insensitivity syndrome patients.
    Kawate H, Wu Y, Ohnaka K, Tao RH, Nakamura K, Okabe T, Yanase T, Nawata H, Takayanagi R.
    J Clin Endocrinol Metab; 2005 Nov 30; 90(11):6162-9. PubMed ID: 16118342
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A novel mutation in the human androgen receptor suggests a regulatory role for the hinge region in amino-terminal and carboxy-terminal interactions.
    Deeb A, Jääskeläinen J, Dattani M, Whitaker HC, Costigan C, Hughes IA.
    J Clin Endocrinol Metab; 2008 Oct 30; 93(10):3691-6. PubMed ID: 18697867
    [Abstract] [Full Text] [Related]

  • 19. Partial androgen insensitivity syndrome with R840H mutation in androgen receptor: report of one case.
    Yen JL, Chang KH, Sheu JC, Lee YJ, Tsai LP.
    Acta Paediatr Taiwan; 2005 Oct 30; 46(2):101-5. PubMed ID: 16302589
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.